A Quicker Pace

Cicović, Aleksandar; Cicovic, Sergej; Wong, Bernard; Støttrup, Nicolaj Brejnholt; Ghattas, Angie; Glenie, Timothy

doi:10.1016/j.jcin.2019.04.024

Cited by 4 publications

(3 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…11 Previous cases reported that IVL induced one case of atrial flutter, one case of atrial fibrillation, three cases of ventricular tachycardia, and one case of ventricular fibrillation. [25][26][27][28][29][30] Hill indicated that male, heart rate <60 beats/min, and total number of IVL pulses are independent predictors of arrhythmia. 15 Sustained ventricular capture can be induced when ion channels are activated and the intrinsic heart rate <60 beats/min or RR interval >1 second.…”

Section: Precautions and Coping Strategiesmentioning

confidence: 99%

“…When acoustic pressure waves activate stretch‐activated ion channels in the cardiac conduction system and depolarize myocardial tissue, the mechanical‐electrical coupling process of the heart is completed 11 . Previous cases reported that IVL induced one case of atrial flutter, one case of atrial fibrillation, three cases of ventricular tachycardia, and one case of ventricular fibrillation 25–30 . Hill indicated that male, heart rate <60 beats/min, and total number of IVL pulses are independent predictors of arrhythmia 15 .…”

Section: Coronary Intravascular Lithotripsy Systemmentioning

confidence: 99%

“… 31 During the testing of the newly implanted implantable cardioverter defibrillator, the electrical energy to induce ventricular tachycardia or ventricular fibrillation was 0.6–2.0 J. Kereiakes considered that the likelihood of inducing ventricular arrhythmias was very low. 11 There were three cases of ventricular tachycardia 27 , 28 , 29 and one case that ventricular ectopic pacing (induced by IVL pulse waves) fell in T‐wave of the previous cardiac cycle to generate ventricular fibrillation. 30 The possibility about IVL‐induced ventricular arrhythmias could not be completely ruled out.…”

Section: Coronary Intravascular Lithotripsy Systemmentioning

confidence: 99%

See 2 more Smart Citations

Intravascular lithotripsy: A novel option for severe calcification of coronary artery

Lv,

Li,

Ren

et al. 2023

Clinical Cardiology

View full text Add to dashboard Cite

BackgroundSevere coronary artery calcification is associated with low success rate of interventional operation, perioperative adverse cardiac events, and poor prognosis, which is a major problem faced by operators. The existing therapy methods all have inherent limitations, such as unsatisfactory balloon crossability, inadequate balloon dilation, and so on. The emergence of intravascular lithotripsy (IVL) has brought the dawn of the treatment of calcified lesions by using unfocused acoustic pressure waves to fracture calcification in situ. And IVL is the only technology capable of targeting deep calcification.HypothesisIVL may have great clinical application values and potential prospects.MethodBased on the existing clinical evidence of IVL and traditional treatment ways, this review discusses the safety and efficacy of IVL. Combined with clinical practice, the precautions and coping strategies of IVL are analyzed. And the review improves the management algorithm of coronary calcification.ResultsIVL has extremely high safety and effectiveness for severe coronary calcification compared with other ways, and structural improvements of IVL will further expand its value.ConclusionsThe emergence of IVL could set off a revolution in the treatment of coronary artery calcification.

show abstract

Section: Precautions and Coping Strategiesmentioning

confidence: 99%

Section: Coronary Intravascular Lithotripsy Systemmentioning

confidence: 99%

Section: Coronary Intravascular Lithotripsy Systemmentioning

confidence: 99%

See 1 more Smart Citation

Intravascular lithotripsy: A novel option for severe calcification of coronary artery

Lv,

Li,

Ren

et al. 2023

Clinical Cardiology

View full text Add to dashboard Cite

show abstract

Intravascular lithotripsy during percutaneous coronary intervention: current concepts

Gardiner

Muradagha

Kiernan

2022

Expert Review of Cardiovascular Therapy

View full text Add to dashboard Cite

Shockwave Intravascular Lithotripsy for the Treatment of Severe Vascular Calcification

et al. 2020

View full text Add to dashboard Cite

Vascular calcification is a highly prevalent pathophenotype that is associated with aging, atherosclerotic cardiovascular disease, diabetes mellitus, and chronic kidney disease. When present, it portends a worse clinical outcome and predicts major adverse cardiovascular events. Heavily calcified coronary and peripheral artery lesions are difficult to dilate appropriately with conventional balloons during percutaneous intervention, and the use of several adjunctive strategies of plaque modification has been suggested. Intravascular lithotripsy (IVL) offers a novel option for lesion preparation of severely calcified plaques in coronary and peripheral vessels. It is unique among all technologies in its ability to modify calcium circumferentially and transmurally, thus modifying transmural conduit compliance. In this article, we summarize the currently available evidence on this technology, and we highlight its best clinical application through appropriate patient and lesion selection, with the main objective of optimizing stent delivery and implantation, and subsequent improved short- and long-term outcomes. We believe that the IVL balloon will transform the market, as it is easy to use, with predictable results. However, cost-effectiveness of such advanced technology will need to be considered.

show abstract

A Quicker Pace

Cited by 4 publications

References 3 publications

Intravascular lithotripsy: A novel option for severe calcification of coronary artery

Intravascular lithotripsy: A novel option for severe calcification of coronary artery

Intravascular lithotripsy during percutaneous coronary intervention: current concepts

Shockwave Intravascular Lithotripsy for the Treatment of Severe Vascular Calcification

Contact Info

Product

Resources

About